AbbVie files lawsuit over drug discount eligibility
The drugmaker seeks clearer federal guidance on patient eligibility for the 340B program. AbbVie argues current loopholes allow for improper discount claims.
Xurve View
Insights:
Xurve View
ABBVIE INC has filed a lawsuit against the government of the United States, seeking clearer guidance on patient eligibility for a federal drug discount program. Under the 340B program, drugmakers are required to supply medicines at significantly reduced prices to eligible healthcare providers serving low-income populations. However, the company is seeking an updated eligibility definition, asserting that existing guidance has created loopholes that allow hospitals and clinics to claim discounts for patients with minimal or unrelated contact.
